Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study

BACKGROUND. Immunosuppression with calcineurin inhibitors (CNIs) is reportedly associated with risk of renal impairment in liver transplant recipients. It is believed that this can be mitigated by decreasing initial exposure to CNIs or delaying CNI introduction until 3–4 d posttransplantation. The A...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transplant Direct
Glavni autori: Friman, Styrbjörn, Tisone, Giuseppe, Nevens, Frederik, Lehner, Frank, Santaniello, Walter, Bechstein, Wolf O., Zhuvarel, Sergey V., Isoniemi, Helena, Rummo, Oleg O., Klempnauer, Jürgen, Anaokar, Swapneel, Hurst, Martin, Kazeem, Gbenga, Undre, Nasrullah, Trunečka, Pavel
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2021
Teme:
Liver Transplantation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274734/
https://ncbi.nlm.nih.gov/pubmed/34263020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001166
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items